Over half of India's top Nifty50 stocks are now trading at lower forward P/E multiples than in 2023, indicating a significant valuation cor...

On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

Lenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.

Indian startup Equal AI has raised $30 million to expand its AI-powered call screening platform that answers and filters calls on users' be...

Happy Friday! Investors are rewriting the rules of engagement with founders after governance blowups. This and more in today’s ETtech Morni...

The round also saw participation from Think Investments, Valiant Fund, PhonePe founder Sameer Nigam, and Zubin Bharti Mittal, among others....

Coca-Cola may list on Indian stock exchanges next year, a significant shift after 50 years. This move could expose inflated valuations due ...

Vodafone Idea shares climbed after shareholders approved a Rs 4,730 crore investment from the Aditya Birla Group, signalling renewed promot...

Venture capital firms are tightening founder contracts, with nearly 76% of Indian startups now allowing the forfeiture of vested shares for...

Acko founder Varun Dua anticipates regulatory changes to insurance distributor commissions will drive consolidation and professionalization...

Carlyle has sought investment bank pitches for a potential India IPO of its healthcare revenue cycle management platform created through th...

PhonePe has introduced SmartPages, an AI tool for merchants. This innovation allows businesses to build payment-ready webpages in under ten...

With Nifty 50 valuations at long-term averages, wealth managers suggest allocating to large-cap stocks. These companies offer stability and...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

When mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...

Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion...

Midcap stocks have dominated performance for a decade, but a shift towards small caps is emerging. Flexi-cap funds are increasing small-cap...